Why CAMP4?
Leadership
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Investors
Newsroom
Join the Adventure
Recent News
October 11, 2024
Camp4 CEO credits CFO, investors’ ‘risk appetite’ for IPO
Read More
Contact Us
Privacy Policy
Terms of Use
Menu
11th October 2024
Camp4 CEO credits CFO, investors’ ‘risk appetite’ for IPO
11th October 2024
Biotech startups Upstream and CAMP4 price Friday IPOs
1st October 2024
CAMP4, BioMarin ink research deal for genetic disease targets
Top
